Name
Arcellx
Company Description
Arcellx, Inc. is a clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx believes that cell therapies are one of the forward pillars of medicine and Arcellx's mission is to advance humanity by developing cell therapies that are safer, more effective, and more broadly accessible. Arcellx's lead product candidate, anito-cel (formerly CART-ddBCMA), is being developed for the treatment of relapsed or refractory multiple myeloma (rrMM) in a Phase 2 pivotal trial.
Website
Product Categories (5)
First-Time Exhibitor
First Time Exhibitor
Yes
Phone (If provided, phone will display online and in-print)
650-799-8071
Address
Redwood City, CA
United States
United States
Recognition
